180 Degree Capital logo

180 Degree Capital

North America, New Jersey, United States, Montclair

Description

180 Degree Capital (NASDAQ: TURN) is a distinctive player in the investment landscape, operating as an internally managed, publicly traded closed-end management investment company. Formerly known as Harris & Harris Group, the firm has evolved its strategy to focus on identifying and investing in what it believes are highly disruptive, small, publicly traded, and pre-IPO companies. Unlike traditional venture capital firms, 180 Degree Capital leverages its public listing to provide liquidity and transparency to its investors while deploying capital into promising enterprises that may be undervalued or misunderstood by the broader market. Their approach emphasizes not just capital infusion but also active, value-added assistance to help portfolio companies scale their commercialization efforts and achieve their strategic objectives.

The firm's investment thesis centers on companies that have moved beyond the early product development phase and are poised for significant commercial growth. They typically target sectors characterized by deep technology, life sciences, and other disruptive innovations. 180 Degree Capital seeks to build meaningful positions in these companies, often taking a significant stake to influence outcomes and unlock value. As of December 31, 2023, the company reported total assets of approximately $37.9 million, reflecting its focused portfolio strategy. Their investments range across various stages, from late-stage private companies with a clear path to liquidity to established small-cap public entities.

180 Degree Capital's unique structure allows it to maintain a long-term perspective on its investments, providing patient capital to companies that require time to mature and realize their full potential. While their portfolio includes a diverse range of companies, a notable example is their significant position in The Arena Group Holdings, Inc., which was valued at over $10 million as of late 2023, demonstrating their capacity for substantial commitments to key holdings. The firm prides itself on its ability to identify overlooked opportunities and apply its expertise to help these companies navigate the complexities of growth and market positioning, ultimately aiming to generate attractive returns for its shareholders.

Investor Profile

180 Degree Capital has backed more than 92 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 3% of its total and boasts 25 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, Canada, United Kingdom.
  • Strong thematic focus on Manufacturing, Biotechnology, Health Care.
  • Typical check size: $500K – $5M.

Stage Focus

  • Series B (27%)
  • Series C (21%)
  • Series Unknown (21%)
  • Series A (14%)
  • Series D (11%)
  • Series E (3%)
  • Debt Financing (2%)
  • Post Ipo Equity (1%)

Country Focus

  • United States (95%)
  • Canada (3%)
  • United Kingdom (2%)

Industry Focus

  • Manufacturing
  • Biotechnology
  • Health Care
  • Electronics
  • Semiconductor
  • Nanotechnology
  • Software
  • Life Science
  • Hardware
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does 180 Degree Capital frequently co-invest with?

Sevin Rosen Funds
North America, Texas, United States, Dallas
Co-Investments: 10
The Aurora Funds
North America, North Carolina, United States, Durham
Co-Investments: 6
ATA Ventures
North America, California, United States, Redwood City
Co-Investments: 6
Apax Partners
Europe, England, United Kingdom, London
Co-Investments: 5
In-Q-Tel
North America, Virginia, United States, Arlington
Co-Investments: 6
El Dorado Ventures
North America, California, United States, Menlo Park
Co-Investments: 6
Lux Capital
North America, New York, United States, New York
Co-Investments: 7
VantagePoint Capital Partners
North America, California, United States, San Bruno
Co-Investments: 7
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 17

Which angels does 180 Degree Capital often collaborate with?

AD
North America, Massachusetts, United States, Boston
Shared Deals: 1
DT
North America, Colorado, United States, Denver
Shared Deals: 1

What are some of recent deals done by 180 Degree Capital?

Magnolia NeuroSciences

New York, New York, United States

Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.

BiotechnologyHealth CareNeuroscienceWellness
Series AAug 13, 2018
Amount Raised: $31,000,000
ORIG3N

Boston, Massachusetts, United States

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

BiotechnologyHealth CareMedicalPersonal Health
Series BJul 12, 2018
Amount Raised: $14,400,000
EchoPixel

Los Altos Hills, California, United States

EchoPixel develops medical imaging devices that enable doctors to use CT images of a patient’s abdomen and display a 3D model.

BiotechnologyHealth CareMedical
Series AOct 19, 2017
Amount Raised: $8,500,000
NGX Bio

South Plainfield, New Jersey, United States

NGX Bio is an online marketplace platform for online DNA sequencing services.

BiotechnologyGeneticsMarketplaceMedicalOnline Portals
Series UnknownAug 15, 2017
Amount Raised: $3,000,000
ORIG3N

Boston, Massachusetts, United States

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

BiotechnologyHealth CareMedicalPersonal Health
Series UnknownJun 27, 2017
Amount Raised: $20,000,000
Lodo Therapeutics

New York, New York, United States

Lodo Therapeutics is a drug discovery and development company.

BiotechnologyHealth CarePharmaceutical
Series AJan 11, 2016
Amount Raised: $17,000,000
Petra Pharma

New York, New York, United States

Petra Pharma is a clinical-stage pharmaceutical company developing a diverse portfolio of novel therapies.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series AJan 6, 2016
Amount Raised: $48,000,000
ORIG3N

Boston, Massachusetts, United States

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

BiotechnologyHealth CareMedicalPersonal Health
Series ADec 12, 2015
Amount Raised: $12,500,000
AgBiome

Raleigh, North Carolina, United States

AgBiome discovers and develops innovative biological and trait products for crop protection.

AgricultureBiotechnologyService Industry
Series BAug 20, 2015
Amount Raised: $34,500,000
ORIG3N

Boston, Massachusetts, United States

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

BiotechnologyHealth CareMedicalPersonal Health
Series UnknownFeb 5, 2015
Amount Raised: $3,100,000